BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma

Clinical trial NCT06793449 · RECRUITING

Trial details

NCT number: NCT06793449
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2025-02-05
Primary completion: 2026-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.